FindTrial
Sign In

A Study on the relation between platelets and liver enzymes with Liver fibroscan to find the severity of liver disease in patients who have non alcoholic fatty liver disease

Association of APRI,FIB-4,AST/ALT with Fibroscan in Patients of Non Alcoholic Fatty Liver Disease for assesing Hepatic Fibrosis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/08/071952
Enrollment
113
Registered
2024-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

Intervention1: Nil: Nil

Sponsors

Department of general medicine
Lead Sponsor
Department of medical gastroenterology
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are diagnosed having NAFLD and NASH , undergoing fibrous scan in kasturba hospital Manipal

Exclusion criteria

Exclusion criteria: Hepatitis B, hepatitis C, auto immune hepatitis, ITP ,history of herbal medication use, history of inherited jaundice

Design outcomes

Primary

MeasureTime frame
Find out association of APRI,FIB-4,AST/ALT ration with fibroscan and using it for assessing hepatic fibrosisTimepoint: Cross sectional study—

Secondary

MeasureTime frame
To find which score among these have better association with fibroscanTimepoint: Cross sectional study—

Countries

India

Contacts

Public ContactDr.Shubhada

Kasturba Medical College and Hospital Manipal

Shubhada.u@manipal.edu9844465447

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026